Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RASBURICASE vs RAVULIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RASBURICASE vs RAVULIZUMAB: Safety Overview

Metric RASBURICASE RAVULIZUMAB
Total FAERS Reports 885 118
Deaths Reported 167 11
Death Rate 18.9% 9.3%
Hospitalizations 412 89
Average Patient Age 51.8 yrs 48.4 yrs
% Female Patients 36.3% 56.3%
Manufacturer Sanofi-Aventis U.S. LLC Alexion Pharmaceuticals Inc.
Route N/A INTRAVENOUS
Marketing Status Prescription N/A